Imalumab

• Description :

  Imalumab (BAX69) is a recombinant, human IgG1 monoclonal antibody that targets macrophage inhibitory factor (MIF) . Imalumab can be used for the research of ovarian carcinoma, recurrent malignant ascites and cancer[1].

• CAS Number :

  [1430205-07-4]

• Product Name Alternative :

  BAX69; Anti-Human MIF Recombinant Antibody

• UNSPSC :

  12352203

• Target :

  Macrophage migration inhibitory factor (MIF)

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Immunology/Inflammation

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/imalumab.html

• Purity :

  98.37

• Solubility :

  10 mM in DMSO

• Smiles :

  [Imalumab]

• Molecular Weight :

  (144.52 kDa)

• References & Citations :

  [1]Bax HJ, et al. Therapeutic targets and new directions for antibodies developed for ovarian cancer. MAbs. 2016 Nov/Dec;8 (8) :1437-1455.|[2]Rossmueller G, et al., Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic. Mol Cancer Ther. 2023 May 4;22 (5) :555-569.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Phase 2